CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
122 hedge funds and large institutions have $524M invested in Clovis Oncology, Inc. in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 49 increasing their positions, 29 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
27% less capital invested
Capital invested by funds: $718M → $524M (-$194M)
32% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 37
Holders
122
Holding in Top 10
5
Calls
$13.6M
Puts
$14.8M
Top Buyers
| 1 | +$40.3M | |
| 2 | +$17.5M | |
| 3 | +$10M | |
| 4 |
SC
Samlyn Capital
New York
|
+$9.31M |
| 5 |
HM
HealthCor Management
New York
|
+$8.92M |
Top Sellers
| 1 | -$23.9M | |
| 2 | -$18.8M | |
| 3 | -$12.7M | |
| 4 |
LPU
Lansdowne Partners (UK)
London,
United Kingdom
|
-$10.7M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$10.1M |